AlphaYou
Overview
Smart money at a glance
Filings to Sep 30, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: both buying and selling, $2K to $30K in total in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- $2K to $30K tradedMixed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 0 added, 2 cutMore cutting
Key stats
Fundamentals Sep 30- Open
- $42.58
- 52-wk high
- $48.76
- High
- $42.75
- 52-wk low
- $35.15
- Low
- $41.94
- Prev close
- $42.10
- Mkt cap
- $19.61B
- P/E
- 17.8x
- Volume
- 2.45M
- Fwd P/E
- 10.6x
- Beta
- 0.59
- Div yield
- 6.08%
- P/S
- 0.8x
- P/B
- 1.7x
- Profit margin
- +4.7%
- Op margin
- +9.7%
- ROE
- +9.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about AMCR filings
Are insiders buying or selling Amcor PLC (AMCR) stock?
Neither. Amcor PLC (AMCR) insiders filed no open-market purchases or sales in the 90 days to Sep 30, 2026, according to SEC Form 4 filings.
Which members of Congress have traded AMCR recently?
Rep. Thomas H. Kean Jr sold $1K to $15K on Aug 10, 2026, disclosed 33 days later. Rep. Thomas H. Kean Jr bought $1K to $15K on May 14, 2026, disclosed 35 days later. In total, 1 member disclosed 2 AMCR trades with trade dates in the last 180 days, filed a median 34 days after trading.
How current is this AMCR smart-money data?
This summary uses filings available on Sep 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (1)
- BO
Bank of America
$191.2M
bought
Sells/Trims (2)
- MI
Millennium
$57.8M
trimmed
- AQ
AQR
$8.0M
trimmed
What Congress is doing
Sells (1)
How top traders are positioned
No tracked top-trader positions in AMCR right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 4.2% above what analysts expected.
Earnings per share
$1.18 expected
Reports Nov 4, 2026, in 35 days
Estimates as of Sep 30, 2026
EPS expected
$0.96 to $1.03
Revenue expected
4 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.08B | $5.75B | $5.91B | $5.91B |
| Cost of what it sold | $4.19B | $4.62B | $4.86B | $4.72B |
| Gross profit | $895.0M | $1.12B | $1.06B | $1.19B |
| What it spent | ||||
| Research and development | $38.0M | $46.0M | $44.0M | $44.0M |
| Sales and admin | $292.0M | $435.0M | $440.0M | $488.0M |
| Other operating costs | $478.0M | $182.0M | $48.0M | $4.85B |
| Total operating expenses | $808.0M | $663.0M | $532.0M | $5.38B |
| What was left | ||||
| Operating profit | $87.0M | $461.0M | $524.0M | $530.0M |
| Interest on debt | $144.0M | $176.0M | $153.0M | $170.0M |
| Profit before tax | -$45.0M | $311.0M | $310.0M | $310.0M |
| Tax | -$6.0M | $49.0M | $32.0M | — |
| Net profit | -$39.0M | $262.0M | $278.0M | $278.0M |
| EBITDA | $420.0M | $851.0M | $943.0M | — |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace